1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global HDAC (Histone Deacetylase) Inhibitors Market 2018 - 2022
- Historic Market Size - Data Table on Global HDAC (Histone Deacetylase) Inhibitors Market 2018 - 2022 ($ million)
- 4.2 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
- 4.3 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Route of Administration
- 6.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)
- 6.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 6.3 Oral HDAC inhibitors - Market size and forecast 2023-2028
- Chart on Oral HDAC inhibitors - Market size and forecast 2023-2028 ($ million)
- Data Table on Oral HDAC inhibitors - Market size and forecast 2023-2028 ($ million)
- Chart on Oral HDAC inhibitors - Year-over-year growth 2023-2028 (%)
- Data Table on Oral HDAC inhibitors - Year-over-year growth 2023-2028 (%)
- 6.4 Parenteral HDAC inhibitors - Market size and forecast 2023-2028
- Chart on Parenteral HDAC inhibitors - Market size and forecast 2023-2028 ($ million)
- Data Table on Parenteral HDAC inhibitors - Market size and forecast 2023-2028 ($ million)
- Chart on Parenteral HDAC inhibitors - Year-over-year growth 2023-2028 (%)
- Data Table on Parenteral HDAC inhibitors - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
7 Market Segmentation by Distribution Channel
- 7.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
- 7.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 7.3 Hospital pharmacies - Market size and forecast 2023-2028
- Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
- 7.4 Retail pharmacies - Market size and forecast 2023-2028
- Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- 7.5 Online pharmacies - Market size and forecast 2023-2028
- Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
- 7.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 7.7 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.11 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 Acrotech Biopharma Inc.
- Acrotech Biopharma Inc. - Overview
- Acrotech Biopharma Inc. - Product / Service
- Acrotech Biopharma Inc. - Key offerings
- 12.4 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- 12.5 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- 12.6 Celleron Therapeutics Ltd.
- Celleron Therapeutics Ltd. - Overview
- Celleron Therapeutics Ltd. - Product / Service
- Celleron Therapeutics Ltd. - Key offerings
- 12.7 Curis Inc.
- Curis Inc. - Overview
- Curis Inc. - Product / Service
- Curis Inc. - Key offerings
- 12.8 Huya Bioscience International LLC
- Huya Bioscience International LLC - Overview
- Huya Bioscience International LLC - Product / Service
- Huya Bioscience International LLC - Key offerings
- 12.9 Italfarmaco Holding SPA
- Italfarmaco Holding SPA - Overview
- Italfarmaco Holding SPA - Product / Service
- Italfarmaco Holding SPA - Key offerings
- 12.10 Medivir AB
- Medivir AB - Overview
- Medivir AB - Product / Service
- Medivir AB - Key offerings
- 12.11 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- 12.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 12.13 Shenzhen Chipscreen Biotechnology Co. Ltd.
- Shenzhen Chipscreen Biotechnology Co. Ltd. - Overview
- Shenzhen Chipscreen Biotechnology Co. Ltd. - Product / Service
- Shenzhen Chipscreen Biotechnology Co. Ltd. - Key offerings
- 12.14 Syndax Pharmaceuticals, Inc
- Syndax Pharmaceuticals, Inc - Overview
- Syndax Pharmaceuticals, Inc - Product / Service
- Syndax Pharmaceuticals, Inc - Key offerings
- 12.15 Valerio Therapeutics
- Valerio Therapeutics - Overview
- Valerio Therapeutics - Product / Service
- Valerio Therapeutics - Key offerings
- 12.16 Viracta Therapeutics Inc.
- Viracta Therapeutics Inc. - Overview
- Viracta Therapeutics Inc. - Product / Service
- Viracta Therapeutics Inc. - Key offerings
- 12.17 Xynomic Pharmaceuticals Nanjing Co. Ltd.
- Xynomic Pharmaceuticals Nanjing Co. Ltd. - Overview
- Xynomic Pharmaceuticals Nanjing Co. Ltd. - Product / Service
- Xynomic Pharmaceuticals Nanjing Co. Ltd. - Key offerings
13 Appendix
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
Get the report (PDF) sent to your email within minutes.